Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 172-180 , May 2007

Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study

Received 19 December 2005 ,Revised 11 July 2006 ,Accepted 22 July 2006.

References 

  1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, et al. Diabetic retinopathy. Diabetes Care. 1998;2:143–156
  2. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy. The EURODIAB IDDM complications study. Diabetologia. 1995;38:437–444
  3. American Diabetes Association . Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1201
  4. American Diabetes Association . Clinical practice recommendations. Diabetes Care. 2002;25(Suppl 1):S1–S147
  5. Bresnick GH. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology. 1983;90:1301–1317
  6. Castell C, Tresserras R, Lloveras G, Goday A, Serra J, Salleras L. Prevalence of diabetes in Catalonia, an OGTT-based population study. Diabetes Research and Clinical Practice. 1999;43:33–40
  7. Consell Assesor sobre Diabetes a Catalunya . Registre de diabetes tipus 1 de Catalunya, 1995–2002. In: Butlleti Epidemiològic de Catalunya. vol. XXIII (4):Barcelona: Departament de Sanitat i Seguretat Social; 2002;
  8. Cunha-Vaz J. Diabetic macular oedema. European Journal of Ophthalmology. 1998;8:127–130
  9. ETDRS . Detection of diabetic macular edema study no. 5. Ophthalmology. 1989;96:746–751
  10. European Diabetes Policy Group. A desktop guide to type I (insulin-dependent) diabetes mellitus, 1998–1999. Guidelines for diabetes care. Diabetic Medicine. 1999;16:253–266
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . Executive summary of the third report of the National Cholesterol Education Program (NCEP). Journal of the American Medical Association. 2001;285:2486–2497
  12. Ferris FL, Chew EY, Hoogwerf BJ. Serum lipids and diabetic retinopathy: Early Treatment of Diabetic Retinopathy Study Research Group. Diabetes Care. 1996;19:1291–1293
  13. Fine BS, Brucker AJ. Macular oedema and cystoid macular oedema. American Journal of Ophthalmology. 1981;92:466–481
  14. Galler A, Muller G, Schinzei R, Kratzsch J, Kiess W, Munch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type I diabetes, as determined by fluorescence spectroscopy and NE-(carboxymethyl-lysine) ELISA. Diabetes Care. 2003;26:2609–2615
  15. Gass JDM, Anderson DR, Davis EB. A clinical, fluoresceinic angiographic, and electron microscopic correlationship of cystoid macular oedema. American Journal of Ophthalmology. 1985;100:82–86
  16. Geiss L, Engelgau M, Fraizer E, Tierney E. Diabetes surveillance, 1997. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 1997;
  17. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, et al. Topography of diabetic macular oedema with optical coherence tomography. Ophthalmology. 1998;105:360–370
  18. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. American Journal of Ophthalmology. 2004;137:313–322
  19. Klein BEK, Klein R, Moss SE. Is serum cholesterol associated with progression of diabetic retinopathy or macular oedema in persons with younger-onset diabetes of long duration?. American Journal of Ophthalmology. 1999;128:652–654
  20. Klein BEK, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Archives of Ophthalmology. 1995;113:601–606
  21. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy: XV. The long term incidence of macular edema. Ophthalmology. 1995;102:7–16
  22. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The 14-year incidence and progression of diabetic retinopathy an associate risk factors in type I diabetes. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. Ophthalmology. 1998;105:1801–1815
  23. Klein R, Marino EK, Kuller LH, Polak JF, Gotdiener JS, Burke GL, et al. The relationship of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the cardiovascular health study. British Journal of Ophthalmology. 2002;86:84–90
  24. Klein R, Moss SE, Klein BEK. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy?. Ophthalmology. 1993;100:1140–1146
  25. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: XI. The incidence of macular edema. Ophthalmology. 1989;96:1501–1510
  26. Klein R, Sharrett AR, Klein BEK, Moss SE, Folsom AR, Wong TY, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes. The Atherosclerosis Risk in Communities Study. Ophthalmology. 2002;109:1225–1234
  27. Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T. Incidence of retinopathy in type I (insulin-dependent) diabetes: Association with clinical nephropathy. Journal of Diabetic Complications. 1987;1:96–99
  28. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. British Medical Journal. 1998;317:703–718
  29. Landmesser U, McOwen MD, Bowen RM, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111:712–715
  30. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type I diabetes. Diabetes. 2004;53:2883–2892
  31. Moss SE, Klein R, Klein BE. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology. 1996;103:1438–1442
  32. Otani T, Kishi S, Maruyana Y. Patterns of diabetic macular edema with optical coherence tomography. American Journal of Ophthalmology. 1999;127:688–693
  33. Romero-Aroca P, Espeso-Sentis O, Sarda-Aure P, del Castillo-Dejardin D. Relationship between microalbuminuria and diabetic retinopathy in type I diabetes mellitus. Revista Clinica Espanola. 2000;200:351–354
  34. Romero-Aroca P, Salvat-Serra M, Mendez-Marin I, Martinez-Salcedo I. Is microalbuminuria a risk factor for diabetic retinopathy?. Journal Français D'ophtalmologie. 2003;26(7):680–684
  35. Sjolie AK, Stephenson J, Aldoington S, Kohner E, Janka H, Stevens L, et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology. 1997;104:252–260
  36. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication Research Group. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy. New England Journal of Medicine. 2000;342:381–389
  37. The Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with type I diabetes mellitus: A seven-year prospective study. Diabetic Medicine. 1999;16:918–925
  38. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine. 1997;157:2413–2442
  39. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–1682

PII: S1056-8727(06)00079-1

doi: 10.1016/j.jdiacomp.2006.07.008

Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 172-180 , May 2007

Article Tools

* Image Usage & Resolution